CYTR SH's would rather see a PR detailing FDA approval of Aldox, or even better, SOON's, or any other BP's BO offer of CYTR, IMO. And I think we can both agree that what PSS says and what actually evolves can differ substantially, but anything positive that impacts CYTR's valuation is welcome anytime!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.